Virpax Pharmaceuticals (VRPX) Pharmaceuticals Updates on Litigation

Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) today announced that it has received a ruling on the lawsuit filed by Scilex Pharmaceuticals (NASDAQ: SCLX) and Sorrento Therapeutics, the now bankrupt majority owner of Scilex Pharmaceuticals.

The Court found in favor of the plaintiffs (on all but three counts deemed to have been waived). However, no damages judgment was specified in the ruling which called for additional proceedings to determine the remedy.

You May Also Be Interested In

• SEGG Media sues short seller for $20M over stock report
• Brera Holdings responds to derivative lawsuit tied to RockawayX deal
• FDA rejects Lantheus drug application over manufacturing issues